Family · Pharmaceutical analytical standards
Melagatran
A direct thrombin inhibitor, blocking the key enzyme of blood clotting: it is the active form of ximelagatran, an oral anticoagulant marketed in some European countries in the mid-2000s and withdrawn in 2006. This family brings together the active ingredient.
Did you know?It was designed starting from the crystal structure of thrombin bound to an inhibitor; since it was poorly absorbed by mouth, it was turned into a 'double prodrug', ximelagatran, the first oral direct thrombin inhibitor to enter clinical trials.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
